	PD-L1 Expression in Uterine Mesenchymal Tumors: A Comparative Immunohistochemical Analysis. J Obstet Gynaecol Res Bahitli FM, Akman L, Serin G, Acar M, Yildirim N, Zekioglu O, Terek MC, Goker E, Ozsaran AA. PMID: 42773568 [PubMed - indexed for MEDLINE]
	Unveiling CCL5: the master regulator of breast cancer progression and immune evasion. Breast Cancer Res Mu J, Zhang M, Chen Q, Liu W, Feng W, Zhang Y. PMID: 42773463 [PubMed - indexed for MEDLINE]
	Recovery of ovarian function after chemotherapy in premenopausal women with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat Huynh PY, Tran BV, Ngo VT, Tran TT. PMID: 42773325 [PubMed - indexed for MEDLINE]
	A retrospective, observational cohort study of treatment patterns and outcomes among patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in the United States following endocrine therapy. Breast Cancer Res Treat O'Shaughnessy J, Rehnquist MK, Sadetsky N, Verret W, Cinar P, Sjekloca N, Nguyen L, Nanda R, Sharma P. PMID: 42773273 [PubMed - indexed for MEDLINE]
	Immunohistochemical expression of p53 is a helpful surrogate marker in the differential diagnosis of primary ovarian mucinous tumors: a large study of 181 cases of mucinous borderline tumor and carcinoma. Virchows Arch Dundr P, Töltési I, Kendall Bárt, Drozenová J, Fabian P, Fadare O, Hausnerová J, Laco J, Lax SF, Mat, Stru, , Weberová B, Stolnicu S, , McCluggage WG, Vránková R, N. PMID: 42773225 [PubMed - as supplied by publisher]
	Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial. Nat Commun Valero V, Pohlmann PR, Mouabbi J, Huang X, Qiao W, Alonzo H, Murthy RK, Rauch GM, Adesoye T, Checka C, Symmans FW, Grachev D, Alajajyan F, Nwosu-Iheme A, Hassan A, Patel M, Giordano SH, Hunt K, Tripathy D, Meric-Bernstam F. PMID: 42773107 [PubMed - indexed for MEDLINE]
	Where do delays occur? A systematic review of the barriers to early breast cancer diagnosis across South Africa's health system. BMJ Open Reissis Y, Miller B, Friebel R, Hargest R. PMID: 42772875 [PubMed - indexed for MEDLINE]
	Remodeling at the intersection of time and tissue: Aging, obesity, and the MT1-MMP proteolytic driver in ovarian cancer. Enzymes Strasiotto BC, Stack MS. PMID: 42772842 [PubMed - indexed for MEDLINE]
	Safety-Oriented Benchmarking of Large Language Models in Risk-Based Management of Abnormal Cervical Screening Results: Scenario-Based Benchmark Study. J Med Internet Res Ero, Ero. PMID: 42772748 [PubMed - indexed for MEDLINE]
	Neoadjuvant antibody-drug conjugates for early-stage breast cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol E Silva GB, Simões AR, Nohmi RL, da Silva RH, de Oliveira Bretas G, Tarantino P, de Oliveira Andrade M. PMID: 42772656 [PubMed - as supplied by publisher]
	Early termination of clinical trials enrolling patients with breast cancer: Reasons, determinants, and temporal patterns. Breast Iannantuono GM, Daniele G, Mastrantoni L, Giannarelli D, Trapani D, Gyawali B, Sganga S, Giudice E, Riondino S, Krasniqi E, Capici S, Pepe FF, Torrisi R, Spinazzola A, Bassolino A, Meacci A, Yazdanpanahardakani K, Padula L, Rosenfeld R, Carbognin L, Lorusso D, Curigliano G, Gulley JL, Fabi A, Bria E, Roselli M, Floudas CS, Cazzaniga ME. PMID: 42772169 [PubMed - as supplied by publisher]
	Anthracycline-free versus anthracycline-based neoadjuvant therapy in HER2-positive breast cancer: A Propensity score-matched real-world study. Cancer Treat Res Commun Sharaf B, Tamimi F, Alzoubi M, Jawarneh Q, Ismail A, Ghanem A, Ata JB, Ajlouni B, Khader R, Jaffal A, Khater S, Jehad S, Abdel-Razeq H. PMID: 42772048 [PubMed - as supplied by publisher]
	Association of community-level social vulnerability with county-level clinical trial access among ovarian cancer patients. Gynecol Oncol O'Connor RM, Sinnott JA, Meade CE, Kanal SA, O'Malley DM, Backes FJ, Felix AS, Chambers LM. PMID: 42771918 [PubMed - as supplied by publisher]
	[Clinicopathological characteristics of human epidermal growth factor receptor-2 1+ cases in breast cancer]. Rev Med Inst Mex Seguro Soc Sánchez-Corona Y, Quiñonez-Urrego EE. PMID: 42771801 [PubMed - indexed for MEDLINE]
	Patient perspective on lymphoedema after breast cancer: evidence for 3D micro-massage compression. Br J Community Nurs Pearce S, Nisbet L. PMID: 42771673 [PubMed - indexed for MEDLINE]
	Impact of Clinicopathologic Factors on Breast Cancer Diagnosed in Pregnancy. Oncology Su M, Patel D, Syed S, Delgado-Ramos G, McArthur H, Patel I, Manohar P, Kanjwal S. PMID: 42771576 [PubMed - as supplied by publisher]
	FDCTGAN: Client-local CTGAN-augmented federated learningÂ for imbalanced breast cancerÂ classification. Technol Health Care Salehpour A, Balafar MA, Souri A. PMID: 42771447 [PubMed - as supplied by publisher]
	Understanding nonresponse and strategies to improve response rates in a randomized controlled trial among breast cancer survivors: the FASTRACS-INSIGHT mixed-methods study. J Cancer Surviv Soulier A, Blazer A, Préau M, Guittard L, Maurin A, Fervers B, Letrilliart L, Carretier J, Broc G, Fassier JB, Péron J, Rouat S, Lamort-Bouché M. PMID: 42771283 [PubMed - as supplied by publisher]
	Informational needs in vulvar cancer and precursor conditions: a social listening study. Support Care Cancer Wouters D, van Lynden van Sandenburg MVGL, Hulscher KK, van Esch EMG, Aarts JWM. PMID: 42771088 [PubMed - indexed for MEDLINE]
	Association Between Sleep Continuity and Cognition in Breast Cancer Survivors: A Cross-Sectional Study. JNCI Cancer Spectr Lampson K, Li X, Jyung H, Yang A, Garland SN, Root JC, Ahles TA, Mao JJ. PMID: 42770868 [PubMed - as supplied by publisher]

Articles 1 - 20 / 335480

Page 1 of 16774



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy